Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Known Risks of GLP-1 Use While Nursing The primary concern with GLP-1 therapy in breastfeeding mothers is not confirmed harm to infants but rather the lack of specific safety data in this population
Improved tolerance supports consistency, which is more important than rapid dose escalation
Semaglutide dosing typically escalates over weeks, and rushing to higher doses or plateauing at a suboptimal level can limit results
Until retatrutide has equivalent data, semaglutide is the evidence-based choice for people with established heart disease
US$ 20.90
US$ 25.92
US$ 20.01
